Wuxi, China

Yangkun Feng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Recognizing Yangkun Feng: Innovator in Medical Imaging Technology

Introduction

Yangkun Feng is an accomplished inventor based in Wuxi, China. He has made significant contributions to the field of medical imaging, specifically focusing on the analysis of clear cell renal cell carcinoma through innovative technologies. With one patent to his name, Feng's work represents a notable advancement in how pathogenic images are interpreted for better healthcare outcomes.

Latest Patents

Feng's patent is titled "Segmentation method for tumor regions in pathological images of clear cell renal cell carcinoma based on deep learning." This groundbreaking invention involves a detailed process of data acquisition and pre-processing, construction, and training of the SENet classification network, and the subsequent prediction of tumor regions. The invention demonstrates a significant improvement in reliability compared to traditional imaging techniques like CT or MRI. By overcoming the limitations of previous research, Feng’s method visually delineates the position and size of tumor regions, aiding medical professionals in understanding the pathogenesis and treatment pathways for clear cell renal cell carcinoma.

Career Highlights

Currently, Yangkun Feng is associated with Wuxi Second People's Hospital, where he applies his expertise in medical imaging and deep learning. His focus on integrating advanced machine learning techniques into clinical practice marks him as a key player in enhancing diagnostic methodologies in oncology.

Collaborations

Throughout his career, Feng has worked alongside notable colleagues such as Ninghan Feng and Hong Tang. Their collective efforts have contributed to advancements in medical imaging and cancer research, pushing the boundaries of how technology can influence patient care.

Conclusion

In summary, Yangkun Feng is an innovative thinker in the realm of medical imaging for clear cell renal cell carcinoma. His patent represents a crucial step forward in the utilization of deep learning technologies in medicine. As the field continues to evolve, Feng's contributions hold the promise of improving diagnostic accuracy and treatment strategies, benefiting both healthcare professionals and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…